Re: “ Judge temporarily blocks Trump move to cut NIH funding ” (Page A1, Feb. 11).

A new cancer breakthrough could prove to be a gamechanger for preventing the spread of breast cancer to other vital organs around a patient's body.

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...

Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...

Although fast food can be a tasty treat, many of your favorite menu items contain some very questionable preservatives, dyes, ...

In his first interview since his wife's death, Caden Hutchins tells TODAY.com about her early symptoms and positive attitude ...

Netflix's new limited series retells the story of a wellness influencer who rejected traditional cancer treatments in favor ...

Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe ...

Business leaders and medical professionals from around the Tri-State turned out to celebrate the Business Courier’s 2025 ...

The Hendrix College Office of Engaged Learning has announced five Odyssey Professorships awarded to seven members of the ...